ISIS PHARMACEUTICALS INC's ticker is ISIS and the CUSIP is 464330109. A total of 245 filers reported holding ISIS PHARMACEUTICALS INC in Q3 2014. The put-call ratio across all filers is 2.06 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $9,401,000 | -35.4% | 232,583 | -8.0% | 0.03% | -19.4% |
| Q2 2015 | $14,545,000 | +12.3% | 252,737 | +24.3% | 0.04% | +16.1% |
| Q1 2015 | $12,949,000 | +11.8% | 203,375 | +8.4% | 0.03% | +6.9% |
| Q4 2014 | $11,585,000 | +72.9% | 187,639 | +8.7% | 0.03% | +81.2% |
| Q3 2014 | $6,700,000 | +5.5% | 172,572 | -6.4% | 0.02% | 0.0% |
| Q2 2014 | $6,350,000 | -25.3% | 184,339 | -6.2% | 0.02% | -33.3% |
| Q1 2014 | $8,496,000 | +19.9% | 196,605 | +10.5% | 0.02% | +9.1% |
| Q4 2013 | $7,086,000 | +8.5% | 177,863 | +2.3% | 0.02% | -4.3% |
| Q3 2013 | $6,528,000 | +27.9% | 173,906 | -8.4% | 0.02% | +9.5% |
| Q2 2013 | $5,102,000 | – | 189,890 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BB BIOTECH AG | 5,729,426 | $364,793,000 | 10.87% |
| DOWLING & YAHNKE LLC | 676,323 | $43,061,000 | 5.38% |
| WILLIAM HARRIS INVESTORS INC | 229,887 | $14,638,000 | 3.84% |
| Opus Point Partners Management, LLC | 60,912 | $3,878,000 | 3.25% |
| Nepsis Inc. | 64,580 | $4,112,000 | 2.48% |
| Private Capital Advisors, Inc. | 106,320 | $6,769,000 | 2.46% |
| PINNACLE ASSOCIATES LTD | 1,889,017 | $120,274,000 | 2.24% |
| MESSNER & SMITH THEME VALUE INVESTMENT MANAGEMENT LTD /CA/ | 20,947 | $1,333,000 | 1.90% |
| Apex Capital Management | 928,654 | $59,127,000 | 1.39% |
| Bellevue Asset Management AG | 147,000 | $9,359,000 | 1.31% |